Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FZL40
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,108
Award facts
- Contract value 100% obligated
- $29,108.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, valued at $29,108.25, was awarded on September 29, 2025, with an ultimate completion date of October 21, 2025. The contract does not utilize a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open federal procurement market. The place of performance is located in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion contract vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical consumables supporting Department of Defense healthcare facilities nationwide. As a primary supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established itself as a critical distributor of both branded and generic prescription drugs, biologics, and specialty medications to military health facilities globally. The award of this Botox delivery order reflects the contractor's ongoing role in supplying injectable pharmaceutical products essential to military medical operations.
Quick answers
Who was awarded contract SPE2DB25FZL40?
SPE2DB25FZL40 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FZL40 worth?
The government has obligated $29,108 on SPE2DB25FZL40.
Is contract SPE2DB25FZL40 an order under another contract?
Yes. SPE2DB25FZL40 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB25FZL40 competed?
The extent of competition for SPE2DB25FZL40 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award